Zydus receives final approval from the USFDA for Febuxostat Tablets
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Selexipag tablet is indicated in adults for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization for PAH
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Topiramate Extended-Release capsule had annual sales of US $68.8 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022)
The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
Prime Minister Narendra Modi attended an event marking the 100th robotic-assisted surgical system installation at U. N. Mehta Institute of Cardiology, Ahmedabad.
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)
Subscribe To Our Newsletter & Stay Updated